One drug that has been tearing up the newsfeed this year is abiraterone, a novel drug in phase II trials for prostate cancer. In February, data was presented at ASCO’s Genito-urinary satellite meeting that looked promising. Dr D.C. Danila and researchers from Memorial Sloan Kettering reported a small phase II trial in castration resistant metastatic [...]
Entries Tagged as 'prostate'
Abiraterone and prostate cancer
September 2nd, 2008 · No Comments · Cougar, abiraterone, biotechnology, cancer, competitive intelligence, oncology, pharma, prostate, strategy
Tags:
15 minutes of fame in oncology
July 23rd, 2008 · No Comments · Cougar, cancer, company news, competitive intelligence, market intelligence, market trends, oncology, prostate
Wow, my blog on abiraterone in advanced prostate cancer got picked up last night by TopUSAsites for prostate cancer. It looks like the drug is going to be a hot topic for a while, but caution against the hype is advised until we see whether reduction in PSA and tumour shrinkage actually translates to what [...]
Tags: